XRP Healthcare M&A Holding Inc. is a Dubai-based healthcare acquisition and technology company, focused on AI-powered healthcare initiatives and pharmacy M&A across Africa. This entity is legally and operationally separate from XRP Healthcare LLC, which manages all XRPH token and digital asset activities. XRP Healthcare M&A Holding Inc. does not issue, control, or benefit from the XRPH token. For digital asset information, visit www.xrphtoken.com.
Retail network access is facilitated through agreements with United Networks of America (UNA). Display of pharmacy brand marks does not imply ownership, endorsement, or direct partnership with XRP Healthcare M&A Holding Inc.
Technology partnerships reflect collaborative or project-based cooperation. Display does not imply equity ownership or endorsement unless expressly stated.
Pharmaceutical and supply relationships reflect existing commercial arrangements within acquired operating entities. Display does not imply exclusivity or endorsement beyond standard commercial supply agreements.
Advisors provide professional services to XRP Healthcare M&A Holding Inc. No partnership or ownership interest is implied unless publicly disclosed.
All third-party trademarks remain the property of their respective owners. Display does not imply endorsement, ownership, or partnership unless expressly stated.
Dec 9, 2025

XRP Healthcare M&A Holding Inc. has entered a defining stage as it advances toward becoming a publicly traded company on the TSX Venture Exchange. The active review now underway represents a significant milestone, confirming that the submission is being formally evaluated within the exchange’s listing framework.
Parallel to this regulatory progress, the company is intensifying development of its cornerstone innovation—the XRPH AI health application. Recent upgrades, such as expanded language capabilities, visual diagnostic support for symptoms and conditions, refined navigation, and a more polished interface, are designed to make the platform accessible to users across diverse regions while preserving medically aligned, practical functionality.
Together, these advancements highlight what has consistently shaped the company’s identity: steady delivery, traceable development, and an unwavering focus on building meaningful health-tech infrastructure. As the TSX-V review moves forward in Canada, product refinement continues at full speed, underscoring XRP Healthcare’s ability to advance regulatory and technological objectives in parallel.
This moment is defined by cohesion—advancing AI capabilities, strengthening the acquisition strategy, and laying the groundwork for future participation in the capital markets.
Those seeking a comprehensive breakdown of the newest app improvements and the current phase of the TSX-V review can explore the complete announcement through the link below.
👉 Read the full press release here:
https://www.einpresswire.com/article/872244453/xrp-healthcare-m-a-holding-inc-expands-xrph-ai-app-features-as-tsx-v-review-continues